U.S. RESEARCH ROUNDUP- Biomea Fusion, BlackRock, Capital Bancorp

Reuters04-02

April 2 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Biomea Fusion, BlackRock and Capital Bancorp on Tuesday.

HIGHLIGHTS

* Biomea Fusion Inc : JP Morgan cuts to neutral from overweight

* BlackRock Inc : JP Morgan raises target price to $767 from $742

* Capital Bancorp Inc : Stephens raises to overweight from equal-weight

* Disc Medicine Inc : Raymond James cuts to outperform from strong buy

* Nasdaq Inc : Piper Sandler raises target price to $73 from $71

Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.

* Altimmune Inc : H.C. Wainwright cuts target price to $12 from $15

* APA Corporation : Roth MKM raises target price to $39 from $37

* Biomea Fusion Inc : JP Morgan cuts target price to $14 from $51

* Biomea Fusion Inc : JP Morgan cuts to neutral from overweight

* Black Diamond Therapeutics : Jefferies assumes coverage With Buy rating; PT $10

* BlackRock Inc : JP Morgan raises target price to $767 from $742

* Capital Bancorp Inc : Stephens raises to overweight from equal-weight

* Capital Bancorp Inc : Stephens raises target price to $28 from $25

* CNX Resources Corp : Roth MKM raises target price to $22

* Coinbase Global Inc : Piper Sandler raises target price to $225 from $165

* Disc Medicine Inc : Leerink Partners cuts target price to $65 from $77

* Disc Medicine Inc : Raymond James cuts to outperform from strong buy

* Disc Medicine Inc : Raymond James cuts target price to $40 from $75

* Distribution Solutions Group Inc : Stephens raises PT to $42 from $38

* Envestnet Inc : D.A. Davidson raises target price to $67 from $62

* GE : JP Morgan cuts target price to $148 from $180

* Generation Bio Co : Jefferies raises target price to $6 from $5

* GoDaddy Inc : JP Morgan raises target price to $136 from $128

* Healthequity Inc : JP Morgan raises target price to $108 from $86

* KB Home : Raymond James raises target price to $81 from $70

* Nasdaq Inc : Piper Sandler raises target price to $73 from $71

* Onemain Holdings Inc : Jefferies reinstates coverage With Buy rating; PT $56

* Powerfleet Inc : Raymond James assumes coverage with outperform rating; PT $7

* Rigel Pharmaceuticals Inc : Jefferies raises target price to $1.65 from $1

* $Sachem Capital Corp(SACH-A)$ : Alliance Global Partners cuts PT to $4 from $4.50

* Targa Resources Corp : JP Morgan raises target price to $126 from $125

* VICI Properties Inc : JP Morgan cuts target price to $36 from $38

* Vislink Technologies Inc : Alliance Global Partners raises PT to $10 from $8.50

(Compiled by Bengaluru Newsroom)

((Diaries@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment